Find in Library

Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset

oleh: P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg